MAPT and amyloidosis: In the case of tau pathology, ApoE4 is associated with higher levels of CSF tau (Toledo et al. 2015) and more neurofibrillary tangles at autopsy (Farfel et al. 2016), although these associations are usually relegated to individuals with high levels of amyloid pathology.